Health
OHDSI awarded $10 MM FDA contract to monitor safety/effectiveness of vaccines, biologics – EurekAlert
A team of observational health data researchers, coordinated by Columbia University, will support an FDA program to conduct safety and effectiveness surveillance…
NEW YORK, NY (Dec. 1, 2020)–Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.
The lead research team, primarily comprised of OHDSI personnel from Columbia University, UCLA, and Northeastern University,…
-
Business18 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business10 hours agoDicker Data rides the AI trend to double digit growth
-
Business14 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
General23 hours agoDenmark summons US envoy over suspected influence operations in Greenland